In those MDS with isolated del(5q) and monoallelic TP53 mutation, as in the therapy-related model described above, progression to AML is generally preceded by acquisition of a complex karyotype, including del(17p) and biallelic TP53 inactivation [65,66] (Figure 2). Here, TP53 is linked to myelodysplastic syndrome.